While cancer is recognized as a multifactorial disease involving numerous signaling pathways and gene networks, our results also indicate that INTS6 may function as an important regulatory component within this complex landscape, contributing to broader mechanisms of tumor progression and drug resistance. The gene discussed is INTS6; the disease is cancer.